• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ECHELON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ECHELON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-ECHELON
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Perforation of Vessels (2135)
Event Date 04/22/2011
Event Type  Injury  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
(b)(6).Repair of intracranial vessel perforation with onyx-18 using an exovascular retreating catheter technique.Journal of neurointerventional surgery.2012;4(2):121-124.Doi:10.1136/jnis.2011.004721 medtronic literature review found reported of no changes in symptoms in three out of four cases in association with onyx administration after catheter perforation of an intracranial vessel during neurovascular interventions.The purpose ofthis article was to describe how onyx administration avoids hemorrhages when catheter perforations occur during neurovascular procedures.The authors reviewed 4 cases of patients being treated for a basilar artery occlusion, stent-assisted re-treatment of a residual aneurysm, arteriovenous malformation, and an m1 occlusion using onyx after a catheter perforation of an intracranial vessel to avoid a hemorrhage.The genders were not disclosed in this article.The article does not state any technical issues during use of the echelon catheter, axium coils, and onyx.In addition, in case one, the neurological exam remained unchanged from preprocedural.At the three month follow up, the patient's modified rankin score was 2.In the second case,  a arteriogram and head ct showed patent vessels and a stable onyx cast during a two year follow up.In the third case no new neurological deficits were found post procedure.Finally, in the fourth case, the thrombolysis in myocardial infarction score was 2.The following intra- or post-procedural outcomes were noted: - intracranial vessel perforation - no changes in symptoms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ECHELON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key15978854
MDR Text Key305492054
Report Number2029214-2022-02117
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-ECHELON
Device Catalogue NumberUNK-NV-ECHELON
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/23/2022
Initial Date FDA Received12/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Life Threatening;
-
-